Related Experiment Videos

Development of mullerian inhibiting substance as an anti-cancer drug

R L Cate, E G Ninfa, D J Pratt

Cold Spring Harbor Symposia on Quantitative Biology

|January 1, 1986

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Patterns of Müllerian Inhibiting Substance Type II and Candidate Type I Receptors in Epithelial Ovarian Cancer.

Current molecular medicine·2016

An albumin leader sequence coupled with a cleavage site modification enhances the yield of recombinant C-terminal Mullerian Inhibiting Substance.

Technology (Elmsford, N.Y.)·2014

Prevalence and penetrance of ZFPM2 mutations and deletions causing congenital diaphragmatic hernia.

Clinical genetics·2014

Skeletal transients during heel and toe strike running and the effectiveness of some materials in their attenuation.

Clinical biomechanics (Bristol, Avon)·2013

Three-dimensional electrogoniometric study of selected knee orthoses.

Clinical biomechanics (Bristol, Avon)·2013

The development of a new femoral brace hinge.

Clinical biomechanics (Bristol, Avon)·2013

See all related articles